Navigation Links
Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

reactions and cardiopulmonary arrest, visit http://www.ERBITUX.com.

Important Safety Information

Grade 3/4 infusion reactions, rarely with fatal outcome (<1 in 1000), occurred in approximately 3% (46/1485) of patients receiving ERBITUX (Cetuximab) therapy. These reactions are characterized by rapid onset of airway obstruction (bronchospasm, stridor, hoarseness), urticaria, hypotension, and/or cardiac arrest. Severe infusion reactions require immediate and permanent discontinuation of ERBITUX therapy.

Most reactions (90%) were associated with the first infusion of ERBITUX despite the use of prophylactic antihistamines. Caution must be exercised with every ERBITUX infusion as there were patients who experienced their first severe infusion reaction during later infusions. A 1-hour observation period is recommended following the ERBITUX infusion. Longer observation periods may be required in patients who experience infusion reactions.

Cardiopulmonary arrest and/or sudden death occurred in 2% (4/208) of patients with squamous cell carcinoma of the head and neck treated with radiation therapy and ERBITUX as compared to none of 212 patients treated with radiation therapy alone. Fatal events occurred within 1 to 43 days after the last ERBITUX treatment. ERBITUX in combination with radiation therapy should be used with caution in patients with known coronary artery disease, congestive heart failure and arrhythmias. Close monitoring of serum electrolytes, including serum magnesium, potassium, and calcium during and after ERBITUX therapy is recommended.

Severe cases of interstitial lung disease (ILD), which was fatal in one case, occurred in less than 0.5% of 774 patients with advanced colorectal cancer (mCRC) receiving ERBITUX. There was one case of ILD reported in 796 patients with head and neck cancer receiving ERBITUX in clinical studies.

In clinical studies of ERBITUX, dermato
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/23/2009)....,Nov.23/PRNewswire/--BioTrendsResearchGroup,Inc.r...report,thesecondinamulti-phasesyndicatedmarketrese...ct,Feraheme,throughthefirstsixmonthsofproductavail...ormationfrom50uniqueNephrologistsandqualitativeinf...eofFeraheme,obstaclestouse,reasonstouse,typicalpat...
(Date:11/23/2009)...Mass.,Nov.23/PRNewswire/--ProteonTherapeutics,Inc....roduct,PRT-201,inend-stagerenaldisease(ESRD)patien...ion.TheAVGstudyrepresentsProteon,ssecondhumanclini...gtheinitiationofaPhase1/2studyofPRT-201inESRDpatie...eationearlierthisyear.Proteonalsoannouncestheappoi...
(Date:11/23/2009)...FRANCISCO,Calif.,Nov.23/PRNewswire-FirstCall/--Ane...LoveandDr.DavidC.U,PrichardhaveagreedtojointheAnes...dmergerbetweenAnesivaandArcionTherapeutics.Complet...totakeplaceatthepreviouslyannouncedAnesiva2009Annu...9:00a.m.PSTat400OysterPoint,Suite107A,SouthSanFran...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Side Effects in Statin Users Linked to Gene Mutation 59474 1Side Effects in Statin Users Linked to Gene Mutation 59474 2Slavica Bio Chem MindUp Cancer Project 28HTDS 29 Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 59470 1Slavica Bio Chem MindUp Cancer Project 28HTDS 29 Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 59470 2Slavica Bio Chem MindUp Cancer Project 28HTDS 29 Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 59470 3Slavica Bio Chem MindUp Cancer Project 28HTDS 29 Research Led To The Identification Of Genes Associated With Lung Cancer Promotion And Progression 59470 4Guardian Recognized for Service Products and Reputation by Independent Research Group 59466 1Guardian Recognized for Service Products and Reputation by Independent Research Group 59466 2Guardian Recognized for Service Products and Reputation by Independent Research Group 59466 3
...o Assess Safety and Pharmacokinetics in additio...ETING, Pa., Jan. 17 Genaera,Corporation (Nasdaq: ...s,begun in study MSI-1436C-103, the ascending sing... in overweight and obese type 2 diabetics.,MSI-143... 2 diabetes and,obesity which works centrally and ...
...rstanding of N-myc,gene,s role in the eyes, growth...s, MEMPHIS, Tenn., Jan. 16 A genetic discovery,l...ospital helps answer a,long-standing mystery about... deeper understanding of how genes coordinate the ...diatric eye cancer progresses., "A series of comp...
Other Medicine Technology:Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436) 2Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436) 3Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436) 4St. Jude Defines Eye Cancer Gene's Role in Retinal Development 2St. Jude Defines Eye Cancer Gene's Role in Retinal Development 3
(Date:11/24/2009)...Data Research, FloatScope is a hand-held ophthalmi... New Westminster, BC (PRWEB) Nov...vice for self-examination of the eye. FloatScope c...uch as floaters and opacities in the cornea and ey..., FloatScope uses a beam of light from a pinhole ...
(Date:11/23/2009)...etermined that only 663,000 of the approximately 3...infection received antiviral therapy between 2002 ... in part because only half of the patients know th...es, by 2030 less than 15% of liver-related deaths ...This study, the first to analyze nationwide practi...
(Date:11/23/2009)...FoundationofAmericaGreaterWashingtonChapter(LFAGW)...ayeducation,adviceandresourcesforthe75,000+peoplew...,s35thAnniversaryLuncheonwillbeheldonSat.,December...Ave.,N.E.,Washington( map ).Dress:Businessattire.L...portunitiesare$1,500including10seats,tableandpromo...
(Date:11/23/2009)...women,s hair loss for almost ten years, Zsanett Si... progress and the secret behind her success with t... video diaries which include a direct comparison o... (PRWeb UK) November 23, 2009 ...has released the video diaries that document her r...
(Date:11/23/2009)...edProductsinHolidayMeals ,, HARRISBURG,Pa.,Nov....asasafeThanksgivingmealthisyear,actingAgricultureS...wbasicfoodsafetystepswhenpreparingdinnerandhandlin...foodhandlingandpreparationguidelinesisacriticalste...idRedding."Ignoringtheimportanceoffoodsafetycouldt...
Breaking Medicine News(10 mins):Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Washington Lupus Chapter Celebrates 35th Anniversary on December 5 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2
...BUS, Ohio A study published in the February issue...000 sports injuries in U.S. high schools in 2005-2...led illegal activity by a referee, official or dis...006 and 2006-2007 National High School Sport-Relat...
...nds those under 60 survived longer than people who...ealthDay News) -- A double lung transplant leads t... patients younger than 60 who are in the final sta...ions for COPD, but it wasn,t clear which procedure...
...BIA, Mo. - The information that a child has been d...emotional tailspin. A new study from a University ...diately consider the major financial struggles tha..., the diagnosis of autism upends your world," said...
...STON, Ill. --- Using virtual peers -- animated lif...onversation of typically developing children -- No...nterventions designed to prepare children with aut...recently presented a preliminary study on the work...
...LIS, Feb. 29 Vallon Holdings, LLC, a,Minneapolis-...d Vallon,LifeScience, a new professional services ...act resources to Minneapolis-St. Paul life science... and,Founder of Vallon LifeScience. "...how to rap...
...n, Belgium Alzheimers disease is the most prevale...ts growing significance in a graying society, some... Bart De Strooper (VIB, K.U.Leuven) has been playi...tionally and internationally − and today he ...
Other Medicine News:Health News:When the rules of the game are broken: Research studies sports injuries related to illegal activity 2Health News:Double Lung Transplant Better for Younger COPD Patients 2Health News:Financial struggles plague families of children with autism 2Health News:Children with autism may learn from 'virtual peers' 2Health News:Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry 2Health News:Bart De Strooper receives prestigious $200,000 Alzheimer Prize 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: